France’s new wave of COVID infections expected to peak end-July -scientist – ET HealthWorld

Paris- A new wave in France of COVID-19 infections fuelled by emerging variants of the disease should peak towards end-July, the French government’s top scientific adviser Jean-Francois Delfraissy said on Thursday. “The peak is not yet here, this peak of infections will probably be for end-July,” Delfraissy told RTL radio. “Then the BA.5 variant will reappear, if it is not overtaken by another variant …in autumn,” he added. France reported new 124,724 coronavirus infections over the past 24 hours, against 77,967 a week ago. The French government also recommended this…

Read More

Higher Covid death rates in low-income nations – ET HealthWorld

New Delhi: A research, led by Dr D Prabhakaran from the Public Health Foundation of India (PHFI), shows 47% of the patients hospitalised due to Covid-19 during the first and second waves had hypertension and 32% had diabetes mellitus – two of the most common cardiovascular risk factors. “Those who succumbed to the disease within 30 days of being hospitalised more often presented with significantly higher heart rate, lower diastolic blood pressures, shortness of breath and more frequently had hypertension, diabetes, coronary heart disease, atrial fibrillation, rheumatic heart disease, Chagas…

Read More

Pfizer signs new $3.2 bln COVID vaccine deal with U.S. government – ET HealthWorld

Pfizer Inc and partner BioNTech SE said on Wednesday they signed a $3.2 billion deal with the U.S. government for 105 million doses of their COVID-19 vaccine, which could be delivered as soon as later this summer. The deal includes supplies of a retooled Omicron-adapted vaccine, pending regulatory clearance, according to Pfizer. Drugmakers have been developing vaccines to target the Omicron variant that became dominant last winter. The average price per dose in the new deal is over $30, a more than 50% increase from the $19.50 per dose the…

Read More

India registers 18,819 new COVID-19 cases, active cases rise to 1,04,555 – ET HealthWorld

New Delhi: India’s COVID-19 vaccination coverage has exceeded 197.61 (1,97,61,91,554) crore. This has been achieved through 2,57,19,005 sessions. So far, more than 3.66 (3,66,66,548) crore adolescents have been administered the first dose of the COVID-19 vaccine. 13,827 patients have recovered in the last 24 hours and the cumulative tally of recovered patients is now at 4,28,22,493. Consequently, India’s recovery rate stands at 98.55 per cent. 18,819 new cases and 39 deaths were reported in the last 24 hours. India’s active caseload currently stands at 1,04,555. Active cases now constitute 0.24…

Read More

Not every fever is Covid; swine flu and dengue on the prowl too: NIV – ET HealthWorld

Pune: Unlike the past three waves of the pandemic, when fever — in most cases — meant Covid, the current period is a mixed bag of seasonal viruses and SARS-CoV-2, experts have said. Scientists from ICMR-NIV said seasonal viruses, including H1N1 (swine flu) and H3N2, are now co-circulating with SARS-CoV-2. Dengue cases are also up, an NIV scientist said. “It’s an overlapping season of flu, SARS-CoV-2 and other respiratory viruses. Not every fever means Covid now. Our study clearly shows that,” the scientist said. Jehangir Hospital‘s infectious diseases expert Dr…

Read More

SKorea approves use of 1st homegrown COVID-19 vaccine from SK Bioscience – ET HealthWorld

Seoul: South Korea on Wednesday approved the use of SKYCovione, the country’s first homegrown COVID-19 vaccine developed by SK Bioscience Co., taking a major step toward achieving vaccine sovereignty in the fight against the pandemic. The Ministry of Food and Drug Safety (MFDS) said it approved the use of SKYCovione, also known as GBP510, through consultations of the ministry’s Final Inspection Committee, following an “item approval” recommendation by MFDS’ Central Pharmaceutical Affairs Council on Monday, Yonhap news agency reported. SKYCovione is the country’s first homegrown vaccine to have successfully completed…

Read More

India registers 14,506 COVID-19 cases, active cases stand at 99,602 – ET HealthWorld

New Delhi: India’s COVID-19 vaccination coverage has exceeded 197.46 Cr (1,97,46,57,138) crore. This has been achieved through 2,56,78,429 sessions. So far, more than 3.65 (3,65,66,839) crore adolescents have been administered with the first dose of COVID-19 vaccine. 11,574 patients have recovered in the last 24 hours and the cumulative tally of recovered patients is now at 4,28,08,666. Consequently, India’s recovery rate stands at 98.56 per cent. 14,506 new cases and 30 deaths were reported in the last 24 hours. India’s Active caseload currently stands at 99,602. Active cases now constitute…

Read More

Amidst spiking COVID-19 cases, MoHFW issues guidelines for States/UTs – ET HealthWorld

New Delhi: While the trajectory of COVID-19 cases has declined significantly from levels that were observed in earlier part of this year, a few States/UTs across the Country are witnessing a sustained upswing in the cases currently. Upcoming months are likely to witness mass gatherings in context of various festivities as well as yatras to be held in different parts of the Country. During many such events/yatras lakhs of individuals undertake intra and inter-state journey spanning hundreds of kilometres with halting points arranged by volunteers and community based social/religious organisations.…

Read More

India’s first mRNA COVID-19 vaccine to get Emergency Use Authorisation soon – ET HealthWorld

New Delhi: The Subject Expert Committee (SEC) in a meeting held on Friday recommended Emergency Use Authorisation (EUA) for India‘s first mRNA COVID-19 vaccine, sources told on Tuesday. The Drugs controller general of India (DCGI) is expected to give Emergency Use Authorisation to Gennova‘s mRNA vaccine any time soon. The SEC under India’s drug regulator found data submitted by Gennova Biopharmaceuticals satisfactory in the Friday meeting, people in the know told ANI. The company submitted data in April and provided additional data in May. Earlier in May, Gennova had released…

Read More

India reports 11,793 new COVID-19 cases, active cases rise to 96,700 – ET HealthWorld

New Delhi: India’s COVID-19 vaccination coverage has exceeded 197.31 (1,97,31,43,196) crore. This has been achieved through 2,56,30,111 sessions. So far, more than 3.64 (3,64,58,204) crore adolescents have been administered with the first dose of COVID-19 vaccine. 9,486 patients have recovered in the last 24 hours and the cumulative tally of recovered patients is now at 4,27,97,092. Consequently, India’s recovery rate stands at 98.57 per cent. 11,793 new cases and 27 deaths were reported in the last 24 hours. India’s Active caseload currently stands at 96,700. Active cases now constitute 0.22…

Read More